The present invention relates to novel substituted pyrazoloazepin-4-ones with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
本发明涉及具有
磷酸二酯酶抑制活性的新型取代
吡唑啉-4-酮化合物,以及它们作为治疗炎症性疾病和症状的治疗剂的用途。